Aisling Capital’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
2017
Q3
$42M Hold
2017
Q2
$38.7M Hold
2017
Q1
$29.6M Sell
2016
Q4
$20.5M Hold
2016
Q3
$22.7M Hold
2016
Q2
$16.2M Hold
2016
Q1
$27.7M Hold
2015
Q4
$36.4M Hold
2015
Q3
$38.6M Hold
2015
Q2
$134M Sell
2015
Q1
$190M Hold
2014
Q4
$83.1M Hold
2014
Q3
$50.3M Hold
2014
Q2
$32.5M Buy